Showing 361 - 380 results of 646 for search '"metabolic syndrome"', query time: 0.11s Refine Results
  1. 361

    At-Home Immersive Virtual Reality Exergames to Reduce Cardiometabolic Risk Among Office Workers: Protocol for a Randomized Controlled Trial by Jing Zhao, Akitomo Yasunaga, Andrew T Kaczynski, Hyuntae Park, Yufeng Luo, Jiuling Li, Ai Shibata, Kaori Ishii, Shohei Yano, Koichiro Oka, Mohammad Javad Koohsari

    Published 2025-01-01
    “…The office worker, as a representative group of physically inactive workers, is exposed to risk factors for metabolic syndrome, which is a primary driver of noncommunicable diseases. …”
    Get full text
    Article
  2. 362
  3. 363

    The Potential Role of Gut Microbiota in the Prevention and Treatment of Lipid Metabolism Disorders by Yan-Jun He, Chong-Ge You

    Published 2020-01-01
    “…Probiotics are also believed to regulate metabolic syndromes by regulating the gut microbiota and are expected to become a new preparation for treating metabolic syndromes. …”
    Get full text
    Article
  4. 364

    Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue by Sofia Dias, Sílvia Paredes, Laura Ribeiro

    Published 2018-01-01
    “…The growing prevalence of metabolic syndrome will certainly contribute to the burden of cardiovascular disease. …”
    Get full text
    Article
  5. 365
  6. 366

    Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases by Francisco A. Monsalve, Radha D. Pyarasani, Fernando Delgado-Lopez, Rodrigo Moore-Carrasco

    Published 2013-01-01
    “…Metabolic syndrome is estimated to affect more than one in five adults, and its prevalence is growing in the adult and pediatric populations. …”
    Get full text
    Article
  7. 367

    Mucus-penetrating microbiota drive chronic low-grade intestinal inflammation and metabolic dysregulation by Melissa C. Kordahi, Noëmie Daniel, Andrew T. Gewirtz, Benoit Chassaing

    Published 2025-12-01
    “…Metabolic syndrome is, in humans, associated with alterations in the composition and localization of the intestinal microbiota, including encroachment of bacteria within the colon’s inner mucus layer. …”
    Get full text
    Article
  8. 368
  9. 369
  10. 370

    Panhypopituitarism due to Absence of the Pituitary Stalk: A Rare Aetiology of Liver Cirrhosis by Marta Gonzalez Rozas, Lidia Hernanz Roman, Diego Gonzalez Gonzalez, José Luis Pérez-Castrillón

    Published 2016-01-01
    “…Patients with hypopituitarism can develop a metabolic syndrome-like phenotype. Insulin resistance is the main pathophysiological axis of metabolic syndrome and is the causal factor in the development of nonalcoholic fatty liver disease (NAFLD). …”
    Get full text
    Article
  11. 371

    Role of Vitamin D in Cardiometabolic Diseases by Chaoxun Wang

    Published 2013-01-01
    “…This paper reviews the definition and pathophysiology of vitamin D deficiency, clinical evidence linking vitamin D and CVD risk, diabetes and its complications, and metabolic syndrome.…”
    Get full text
    Article
  12. 372

    Pathophysiologic Mechanisms of Cardiovascular Disease in Obstructive Sleep Apnea Syndrome by Carlos Zamarrón, Luis Valdés Cuadrado, Rodolfo Álvarez-Sala

    Published 2013-01-01
    “…In addition, OSAS is associated with other disorders and comorbidities which worsen cardiovascular consequences, such as obesity, diabetes, and metabolic syndrome. Metabolic syndrome is an emerging public health problem that represents a constellation of cardiovascular risk factors. …”
    Get full text
    Article
  13. 373

    Concentrations of Selected Adipokines, Interleukin-6, and Vitamin D in Patients with Papillary Thyroid Carcinoma in Respect to Thyroid Cancer Stages by Jakub Warakomski, Ewa Romuk, Barbara Jarząb, Jolanta Krajewska, Lucyna Siemińska

    Published 2018-01-01
    “…There were no differences in the prevalence of microcarcinomas in analyzed groups (BMI ≥ 25 versus BMI < 25 and with metabolic syndrome presence versus without metabolic syndrome). …”
    Get full text
    Article
  14. 374
  15. 375
  16. 376

    Rimonabant: From RIO to Ban by Amir H. Sam, Victoria Salem, Mohammad A. Ghatei

    Published 2011-01-01
    “…Endocannabinoid antagonism as a treatment for obesity and the metabolic syndrome became a hugely anticipated area of pharmacology at the start of the century. …”
    Get full text
    Article
  17. 377

    Stress in Obesity and Associated Metabolic and Cardiovascular Disorders by Paul Holvoet

    Published 2012-01-01
    “…Obesity has significant implications for healthcare, since it is a major risk factor for both type 2 diabetes and the metabolic syndrome. This syndrome is a common and complex disorder combining obesity, dyslipidemia, hypertension, and insulin resistance. …”
    Get full text
    Article
  18. 378
  19. 379

    Intrauterine Growth Retardation and Nonalcoholic Fatty Liver Disease in Children by Anna Alisi, Nadia Panera, Carlo Agostoni, Valerio Nobili

    Published 2011-01-01
    “…In this paper, we outline clinical and experimental evidences of the association between IUGR, metabolic syndrome, insulin resistance, and NAFLD and discuss on a possible management to avoid the risk of MS in adulthood.…”
    Get full text
    Article
  20. 380

    Decreased Sex Hormone-Binding Globulin Indicated Worse Biometric, Lipid, Liver, and Renal Function Parameters in Women with Polycystic Ovary Syndrome by Xi Luo, Xin-Ming Yang, Wang-Yu Cai, Hui Chang, Hong-Li Ma, Yan Peng, Xiao-Ke Wu

    Published 2020-01-01
    “…SHBG can be used as a tool to screen metabolic syndrome. This trial is registered with NCT01573858 and ChiCTR-TRC-12002081.…”
    Get full text
    Article